Old Web
English
Sign In
Acemap
>
authorDetail
>
Saku Miyamoto
Saku Miyamoto
Takeda Pharmaceutical Company
Biology
Chemistry
Pharmacology
In vivo
In vitro
5
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes
2017
Bioorganic & Medicinal Chemistry
Yoshihiro Banno
Shigekazu Sasaki
Makoto Kamata
Jun Kunitomo
Yasufumi Miyamoto
Hidenori Abe
Naohiro Taya
Satoru Oi
Masanori Watanabe
Tomoko Urushibara
Masatoshi Hazama
Shin-Ichi Niwa
Saku Miyamoto
Akira Horinouchi
Ken-Ichi Kuroshima
Nobuyuki Amano
Shin-ichi Matsumoto
Shinichiro Matsunaga
Show All
Source
Cite
Save
Citations (2)
Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats
2009
Toxicology Mechanisms and Methods
Saku Miyamoto
Akemi Matsumoto
Ikuo Mori
Akira Horinouchi
Show All
Source
Cite
Save
Citations (20)
Gène spécifique d'un organe, procédé d'identification de celui-ci et son utilisation
2007
Saku Miyamoto
Kenji Takami
Akira Horinouchi
Show All
Source
Cite
Save
Citations (0)
Gène spécifique à un organe, procédé pour l'identifier et son utilisation
2007
Saku Miyamoto
Kenji Takami
Akira Horinouchi
Show All
Source
Cite
Save
Citations (0)
Erythropoietin mRNA in hepatocellular carcinomas and kidney in male B6C3F1 mice with secondary polycythemia
1998
Toxicologic Pathology
Akira Horinouchi
Saku Miyamoto
Masahiro Sekiguchi
Hisako Doi
Shuzo Okazaki
Takao Ando
Show All
Source
Cite
Save
Citations (2)
1